From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

about

3D-Printed PCL/PLA Composite Stents: Towards a New Solution to Cardiovascular Problems

P2860

Q58749531-B070C923-7FD2-4751-95BE-62FEAA719912

P2860

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

Item

http://www.wikidata.org/entity/Q38702003

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

@en

type

Item

label

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

@en

prefLabel

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

@en

P1476

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

@en

P2093

Christos Bourantas

http://www.w3.org/2001/XMLSchema#string

Hiroki Tateishi

http://www.w3.org/2001/XMLSchema#string

Mustafa Yılmaz

http://www.w3.org/2001/XMLSchema#string

Patrick W Serruys

http://www.w3.org/2001/XMLSchema#string

Yaping Zeng

http://www.w3.org/2001/XMLSchema#string

Yohei Sotomi

http://www.w3.org/2001/XMLSchema#string

Yoshinobu Onuma

http://www.w3.org/2001/XMLSchema#string

P2860

Current status of bioresorbable scaffolds in the treatment of coronary artery disease

Bioresorbable scaffolds: rationale, current status, challenges, and future.

Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

A novel approach to temporary stenting: degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits.

The resolute™ integrity zotarolimus-eluting stent in coronary artery disease: a review.

Adjusting a polymer formulation for an optimal bioresorbable stent: a 6-month follow-up study.

Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months.

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.

P304

271-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17434440.2016.1143356

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rafael Cavalcante

Erhan Tenekecioglu

Mohammad Abdelghani

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291166614

http://www.w3.org/2001/XMLSchema#string

P698

26782080

http://www.w3.org/2001/XMLSchema#string

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

about

P2860

P2860

From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698